Eckert & Ziegler BEBIG SA logo

EZBG - Eckert & Ziegler BEBIG SA Share Price

€16.3 0.0  0.0%

Last Trade - 18/02/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £22.5m
Position in Universe th / 846
Bullish
Bearish
Unlock EZBG Revenue
Momentum
Relative Strength (%)
1m +13.0%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2012 2013 2014 2015 2016 2017 2018E 2019E CAGR / Avg
31.8 27.8 28.8 31.1 24.9 25.9 -4.0%
+164.6 -10.8 -95.8
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2018, Eckert &Ziegler Bebig SA revenues increased 16% to EUR14.3M. Netincome decreased 50% to EUR712K. Revenues reflect anincrease in demand for the Company's products and servicesdue to favorable market conditions. Net income was offsetby Other operating income decrease of 77% to EUR172K(income), Selling expenses increase of 19% to EUR3.5M(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

EZBG Revenue Unlock EZBG Revenue

Net Income

EZBG Net Income Unlock EZBG Revenue

Normalised EPS

EZBG Normalised EPS Unlock EZBG Revenue

PE Ratio Range

EZBG PE Ratio Range Unlock EZBG Revenue

Dividend Yield Range

EZBG Dividend Yield Range Unlock EZBG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
EZBG EPS Forecasts Unlock EZBG Revenue
Profile Summary

Eckert & Ziegler BEBIG SA is a Belgium-based company involved in the active implantable medical devices segment of the health care sector. The Company designs, develops and distributes interstitial implants used in brachytherapy for the treatment of cancer. The Company produces and markets three lines of products: Permanent implant brachytherapy, using iodine-125 (125I) implants, mainly for treating prostate cancer; Temporary brachytherapy, using ruthenium-106 (106Ru) plaques, for treating eye cancer, and Temporary brachytherapy, using high speed source projectors (MultiSource), which make it possible to treat cancer of the head, the neck, the brain and certain gynecological cancers. It operates through Mick Radio Nuclear Instruments, Inc. (MRNI), which is involved in the development of applicators for brachytherapy, Wolf-Medizintechnik GmbH and through a Belgian provider of brachytherapy accessories.

Directors
Last Annual December 31st, 2017
Last Interim June 30th, 2018
Incorporated February 15, 1996
Public Since February 27, 1997
No. of Shareholders: n/a
No. of Employees: 197
Sector Healthcare
Industry Healthcare Providers & Services
Index
Exchange Euronext - Brussels
Shares in Issue 2,832,500
Free Float (0.0%)
Eligible for
ISAs
SIPPs
EZBG Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for EZBG
Upcoming Events for EZBG
Frequently Asked Questions for Eckert & Ziegler BEBIG SA
What is the Eckert & Ziegler BEBIG SA share price?

As of 18/02/19, shares in Eckert & Ziegler BEBIG SA are trading at €16.3, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Eckert & Ziegler BEBIG SA share price performed this year?

Shares in Eckert & Ziegler BEBIG SA are currently trading at €16.3 and the price has moved by 87.36% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Eckert & Ziegler BEBIG SA price has moved by 79.07% over the past year.

What are the analyst and broker recommendations for Eckert & Ziegler BEBIG SA?

There are no analysts currently covering Eckert & Ziegler BEBIG SA.

When will Eckert & Ziegler BEBIG SA next release its financial results?

Eckert & Ziegler BEBIG SA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2019-06-30
What is the Eckert & Ziegler BEBIG SA dividend yield?

Eckert & Ziegler BEBIG SA does not currently pay a dividend.

Does Eckert & Ziegler BEBIG SA pay a dividend?

Eckert & Ziegler BEBIG SA does not currently pay a dividend.

When does Eckert & Ziegler BEBIG SA next pay dividends?

Eckert & Ziegler BEBIG SA does not currently pay a dividend.

How do I buy Eckert & Ziegler BEBIG SA shares?

To buy shares in Eckert & Ziegler BEBIG SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Eckert & Ziegler BEBIG SA?

Shares in Eckert & Ziegler BEBIG SA are currently trading at €16.3, giving the company a market capitalisation of £n/a.

Where are Eckert & Ziegler BEBIG SA shares listed? Where are Eckert & Ziegler BEBIG SA shares listed?

Here are the trading details for Eckert & Ziegler BEBIG SA:

Country of listing: Belgium
Exchange: BRU
Ticker Symbol: EZBG
What kind of share is Eckert & Ziegler BEBIG SA?

We were not able to load our ranking data for Eckert & Ziegler BEBIG SA

Is there a Eckert & Ziegler BEBIG SA share price forecast 2021?

We were not able to load any forecast data for Eckert & Ziegler BEBIG SA.

How can I tell whether the Eckert & Ziegler BEBIG SA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Eckert & Ziegler BEBIG SA. Over the past six months, the relative strength of its shares against the market has been 65.37%. At the current price of €16.3, shares in Eckert & Ziegler BEBIG SA are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Eckert & Ziegler BEBIG SA PE Ratio?

We were not able to find PE ratio data for Eckert & Ziegler BEBIG SA.

Who are the key directors of Eckert & Ziegler BEBIG SA?

Eckert & Ziegler BEBIG SA's management team is headed by:

Edgar Loeffler - MDR
Andre Hess - DRC
Andreas Eckert - CHM
Martin Hoelscher - IND
Frank Perschmann - DRC
Susanne Becker - IND
Michael Friebe - IND
Abel Luzuriaga - MDR
Who are the major shareholders of Eckert & Ziegler BEBIG SA?

Here are the top five shareholders of Eckert & Ziegler BEBIG SA based on the size of their shareholding:

Similar to EZBG
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.